MIR3180-1: A Potential Drug Target and Biomarker (G100422870)
MIR3180-1: A Potential Drug Target and Biomarker
Mir3180-1, a protein encoded by the human gene MIR3180-1, is a potential drug target and biomarker that has been identified for its role in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and expression pattern have made it an attractive target for researchers to investigate, and its potential as a drug may have significant implications for the treatment of these diseases.
The MIR3180-1 gene is located on chromosome 6p21.2 and encodes a protein of 21 kDa, which is expressed in various tissues and cells of the body. The protein has a unique structure, with a distinct N-terminus, a potential N-cadherin-like domain, and a C-terminus that is rich in amino acids, including glutamic acid, aspartic acid, and glycine. The C-terminus of MIR3180-1 is also known for its unique post-translational modification, which involves the addition of a modified amino acid, alanine, to the C-terminus.
MIR3180-1 has been shown to play a role in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, MIR3180-1 has been shown to promote the growth and survival of cancer cells, and it has also been linked to the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. In addition, MIR3180-1 has been shown to contribute to the development of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis.
The potential drug target for MIR3180-1 is its unique structure and expression pattern, which have made it an attractive target for researchers to investigate. The N-terminus of MIR3180-1 has a potential N-cadherin-like domain, which is known for its role in cell-cell adhesion. The C-terminus of MIR3180-1 is also rich in amino acids, which may make it a potential target for small molecules or antibodies that can modulate its activity.
In addition to its potential drug target properties, MIR3180-1 has also been shown to have potential as a biomarker. The expression of MIR3180-1 has been shown to be downregulated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that MIR3180-1 may be a useful biomarker for these diseases, as targeting its expression or activity may have potential therapeutic implications.
In conclusion, MIR3180-1 is a protein that has potential as a drug target and biomarker. Its unique structure and expression pattern make it an attractive target for researchers to investigate, and its potential as a drug or biomarker may have significant implications for the treatment of various diseases. Further research is needed to fully understand the role of MIR3180-1 in disease, and to explore its potential as a drug or biomarker.
Protein Name: MicroRNA 3180-1
The "MIR3180-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3180-1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186 | MIR3187 | MIR3188 | MIR3189 | MIR3190 | MIR3191 | MIR3192 | MIR3193 | MIR3194 | MIR3195 | MIR3196 | MIR3197 | MIR3198-1 | MIR3199-1 | MIR3199-2 | MIR31HG | MIR32 | MIR3200 | MIR3201 | MIR3202-1 | MIR3202-2 | MIR320A | MIR320B1 | MIR320B2 | MIR320C1 | MIR320C2 | MIR320D1 | MIR320D2 | MIR320E | MIR323A | MIR323B | MIR324 | MIR325 | MIR325HG | MIR326 | MIR328 | MIR329-1 | MIR329-2 | MIR330 | MIR331 | MIR335 | MIR337 | MIR338 | MIR339 | MIR33A | MIR33B | MIR340 | MIR342 | MIR345 | MIR346 | MIR34A | MIR34AHG | MIR34B | MIR34C | MIR3529 | MIR3591 | MIR3605 | MIR3606 | MIR3609 | MIR361 | MIR3610 | MIR3611 | MIR3612 | MIR3613 | MIR3614 | MIR3615 | MIR3616 | MIR3617 | MIR3618 | MIR3619 | MIR362 | MIR3620 | MIR3621 | MIR3622A | MIR3622B | MIR363 | MIR3646 | MIR3648-1 | MIR3649 | MIR3650 | MIR3651 | MIR3652 | MIR3654 | MIR3655 | MIR3658 | MIR3659 | MIR365A | MIR365B | MIR3660 | MIR3661 | MIR3662 | MIR3663
